What on-body subcutaneous systems are currently marketed or in development, who are the suppliers, and what are the device specifics?

The statistical comparison of the defibrillation thresholds for the devices was performed with the use of a paired t-test. After completion of the study, the subcutaneous device was explanted.

The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

The global market for subcutaneous biologics is expected to reach new heights amid growing trends towards self-administration therapies and continuous technological development in biologic drug ...

The LifeSite subcutaneous access system allows immediate hemodialysis after implantation. The device consists of a silicone cannula, which is placed in a central venous location (usually via the ...

Once the patient attaches the device onto the injection site and pushes the activation button, the automatic infusion of the drug into the subcutaneous tissue commences. With the size, shape and ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.

Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease ...

The new retrospective study adds to a growing body of research showing benefits of subcutaneous anchor devices, including a 2020 study that showed reduced risk of bloodstream infections and a 2022 ...

The subcutaneous layer, or hypodermis, is the deepest layer of skin tissue. It consists mostly of fat and keeps the body warm.

A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in ...